Ghim Mean, Wei Linyan, Jung Jae-Joon, The Erlinda, Kukreja Gunjan, Neishabouri Afarin, Ahmad Azmi A, Raza M Zawwad, Golbazi Arvene, Hedayatyanfard Keshvad, Nie Lei, Zhang Jiasheng, Sadeghi Mehran M
bioRxiv. 2024 Aug 23:2024.08.22.609269. doi: 10.1101/2024.08.22.609269.
The neuropilin-like, Discoidin, CUB and LCCL domain containing 2 (DCBLD2) is a transmembrane protein with an unusually long signal sequence (SS) composed of N-terminal (N) and C-terminal (C) subdomains, separated by a transition (tra) subdomain. DCBLD2 interacts with VEGFR-2 and regulates VEGF-induced endothelial cell signaling, proliferation and migration, as well as angiogenesis. The exact mechanisms by which DCBLD2 interacts with VEGFR2 to modulate VEGF signaling remain unclear.
Searching for VEGFR2 interacting DCBLD2 domains, we generated various constructs containing different DCBLD2 domain combinations and conducted co-immunoprecipitation and signaling studies in HEK 293T and endothelial cells. Several peptides were synthesized based on the identified domain, and their effect on VEGF signaling was assessed in vitro in cell culture and in vivo using matrigel plug and corneal micropocket assays. The effect of the lead peptide was further evaluated using a murine hindlimb ischemia model.
DCBLD2 SS interacted with VEGFR2 and promoted VEGF signaling. SS was not cleaved in the mature DCBLD2 and its hydrophobic transmembrane 'traC' segment, but not the 'N' subdomain, was involved in DCBLD2-VEGFR2 interaction. The smallest unit in DCBLD2 SS that interacts with VEGFR2 was the L5VL5 sequence. Even after the central valine was removed, the L10 sequence mimicked the DCBLD2 SS traC's effect on VEGF-signaling, while shorter or longer poly-leucine sequences were less effective. Finally, a synthetic traC peptide enhanced VEGF signaling in vitro, promoted VEGF-induced angiogenesis in vivo, and improved blood flow recovery following hindlimb ischemia.
DCBLD2 SS along with its derivative peptides can promote VEGFR2 signaling and angiogenesis. Synthetic peptides based on DCBLD2 SS hold promise as therapeutic agents for regulating angiogenesis. Importantly these findings refine the traditional view of signal sequences as mere targeting elements, revealing a role in cellular signaling. This opens new avenues for research and therapeutic strategies.
类神经纤毛蛋白、盘状结构域、CUB结构域和LCCL结构域包含蛋白2(DCBLD2)是一种跨膜蛋白,具有异常长的信号序列(SS),该信号序列由N端(N)和C端(C)亚结构域组成,中间由一个过渡(tra)亚结构域隔开。DCBLD2与血管内皮生长因子受体2(VEGFR-2)相互作用,调节血管内皮生长因子(VEGF)诱导的内皮细胞信号传导、增殖和迁移以及血管生成。DCBLD2与VEGFR2相互作用以调节VEGF信号传导的确切机制尚不清楚。
为了寻找与VEGFR2相互作用的DCBLD2结构域,我们构建了包含不同DCBLD2结构域组合的各种构建体,并在人胚肾293T细胞(HEK 293T)和内皮细胞中进行了免疫共沉淀和信号传导研究。基于鉴定出的结构域合成了几种肽,并在细胞培养物中体外评估了它们对VEGF信号传导的影响,以及在体内使用基质胶栓塞和角膜微袋试验进行了评估。使用小鼠后肢缺血模型进一步评估了先导肽的作用。
DCBLD2信号序列与VEGFR2相互作用并促进VEGF信号传导。信号序列在成熟的DCBLD2中未被切割,其疏水跨膜“traC”片段而非“N”亚结构域参与了DCBLD2与VEGFR2的相互作用。DCBLD2信号序列中与VEGFR2相互作用的最小单位是L5VL5序列。即使去除中间的缬氨酸,L10序列仍模拟DCBLD2信号序列traC对VEGF信号传导的作用,而更长或更短的多亮氨酸序列效果较差。最后,一种合成traC肽在体外增强了VEGF信号传导,在体内促进了VEGF诱导的血管生成,并改善了后肢缺血后的血流恢复。
DCBLD2信号序列及其衍生肽可促进VEGFR2信号传导和血管生成。基于DCBLD2信号序列的合成肽有望成为调节血管生成的治疗药物。重要的是,这些发现完善了传统观点中信号序列仅仅作为靶向元件的看法,揭示了其在细胞信号传导中的作用。这为研究和治疗策略开辟了新途径。